Fragment 176-191 & CJC-1295 & Ipamorelin Blend 12mg

Description

This three-peptide research blend combines Fragment 176-191 (fat-targeting GH fragment), CJC-1295 without DAC (GHRH analogue), and Ipamorelin (GH secretagogue) for comprehensive metabolic and GH axis research. Allows researchers to study both growth hormone secretion pathways and direct lipolytic activity simultaneously. Nexopep supplies this blend in a single lyophilised 12mg vial independently tested for purity. For laboratory research use only.